Skip to content
Search

Capital at risk. Past performance is not a reliable indicator of current or future results and should not be the sole factor of consideration when selecting a product or strategy.

The listed funds are not an exhaustive list of funds available. Visit www.funds.troweprice.com to see the full range of funds offered by T. Rowe Price, including those that consider environmental and social characteristics as part of their investment process.  For up to date information regarding any T. Rowe Price fund's investment strategy, please see the relevant fund KID and prospectus. 

SICAV
European Smaller Companies Equity Fund
An actively managed, diversified growth portfolio of around 70-100 small- and mid-cap European companies. Environmental, Social and Governance (ESG) considerations are integrated into the investment process as a component of the investment decision. The fund is categorised as Article 8 under Sustainable Finance Disclosure Regulation (SFDR).
ISIN LU0382931417
View more information on risks
FACTSHEET
KID
SFDR DISCLOSURE
30-Nov-2024 - Ben Griffiths, Portfolio Manager,
Major external disruptions—the coronavirus pandemic, the collapse in supply chains, prolonged destocking, weakness in China—appear to be normalising. We believe this should benefit our higher quality, higher growth portfolio. We are also maintaining balance, and are therefore well invested in sectors which will likely thrive in an inflationary environment.

Overview
Strategy
Fund Summary
Our approach incorporates intensive, fundamental research seeking to identify small and mid-sized companies capable of sustaining above-average, long-term earnings growth and selling at reasonable prices. We aim to discover attractive companies at an early stage and hold them while they compound appreciably over the long term. The promotion of environmental and/or social characteristics is achieved through the fund's commitment to maintain at least 10% of the value of its portfolio invested in Sustainable Investments, as defined by the SFDR. Additionally, we apply a proprietary responsible screen (exclusion list). The manager is not constrained by the fund’s benchmark, which is used for performance comparison purposes only.
Performance - Net of Fees

Past performance is not a reliable indicator of future performance.

30-Nov-2024 - Ben Griffiths, Portfolio Manager,
Smaller company shares in Europe rose in November on expectations of more policy easing by the European Central Bank, as fears of a global trade war and intensifying political worries added to concerns about a slowing economy. Small-caps beat their large- and mid-cap peers, while the value index continued to advance more than the growth equivalent. At the portfolio level, stock selection in health care, real estate and financials dragged most on relative performance. In health care, a speciality pharmaceutical company was the worst performer. The business posted strong earnings for the third quarter but lowered guidance for 2025 as a partner that makes vaccines reduced sales expectations and because of a decision not to commercialise a drug in the US. However, stock selection in communication services and consumer staples contributed positively. An owner of classified portals in the Nordic region performed best in communication services. The shares continued to march higher as brokers expected first-half results for fiscal year 2025 to show solid revenue growth across the key verticals of autos, real estate and jobs and services.
31-Jan-2024 - Ben Griffiths, Portfolio Manager,
We maintained a tight focus on risk management and valuations and sought to identify opportunities among cheap high-quality growth companies with strong balance sheets and capable management teams. We trimmed our above-benchmark position in information technology (IT), exiting a provider of IT infrastructure and services, due to a broken investment thesis. We expected the stock to benefit from a structural IT upgrade in Germany but fiscal tightening is restricting the public sector’s ability to expand IT spending. We also reduced our allocation to health care, exiting a drug research alliance and development partnership company after sudden management changes.

Past performance is not a reliable indicator of future performance.

The Funds are sub-funds of the T. Rowe Price Funds SICAV, a Luxembourg investment company with variable capital which is registered with Commission de Surveillance du Secteur Financier and which qualifies as an undertaking for collective investment in transferable securities (“UCITS”). Full details of the objectives, investment policies and risks are located in the prospectus which is available with the key investor information documents and/or key information document (KID) in English and in an official language of the jurisdictions in which the Funds are registered for public sale, together with the articles of incorporation and the annual and semi-annual reports (together “Fund Documents”). Any decision to invest should be made on the basis of the Fund Documents which are available free of charge from the local representative, local information/paying agent or from authorised distributors. They can also be found along with a summary of investor rights in English at www.troweprice.com. The Management Company reserves the right to terminate marketing arrangements.

Hedged share classes (denoted by 'h') utilise investment techniques to mitigate currency risk between the underlying investment currency(ies) of the fund and the currency of the hedged share class.  The costs of doing so will be borne by the share class and there is no guarantee that such hedging will be effective.

Before deciding to invest in the fund, you should read the offering document/prospectus (including its investment objectives, policies and any risk warnings) which are available and may be obtained from any appointed distributors.

The specific securities identified and described in this website do not represent all of the securities purchased, sold, or recommended for the sub-fund and no assumptions should be made that the securities identified and discussed were or will be profitable.

A full list of the currently issued Share Classes including Distributing, Hedged, and Accumulating Categories may be obtained, free of charge and upon request, from the registered office of the Company.  

Benchmark: Investors may use the benchmark to compare the fund’s performance. The benchmark has been selected because it is similar to the investment universe used by the investment manager and therefore acts as an appropriate comparator. The investment manager is not constrained by any country, sector and/or individual security weightings relative to the benchmark and has complete freedom to invest in securities that do not form part of the benchmark.

Disclosure on Vendor Indices can be found here.